IDEXX Laboratories Inc. (IDXX): Price and Financial Metrics

IDEXX Laboratories Inc. (IDXX): $482.60

16.78 (+3.60%)

POWR Rating

Component Grades








IDXX Price/Volume Stats

Current price $482.60 52-week high $564.73
Prev. close $465.82 52-week low $372.50
Day low $464.59 Volume 479,628
Day high $484.06 Avg. volume 463,589
50-day MA $437.80 Dividend yield N/A
200-day MA $476.34 Market Cap 40.08B

IDXX Stock Price Chart Interactive Chart >


  • Quality is the dimension where IDXX ranks best; there it ranks ahead of 94.16% of US stocks.
  • The strongest trend for IDXX is in Stability, which has been heading down over the past 177 days.
  • IDXX's current lowest rank is in the Momentum metric (where it is better than 13.79% of US stocks).

IDXX Stock Summary

  • IDEXX LABORATORIES INC's market capitalization of $35,606,756,198 is ahead of 93.59% of US-listed equities.
  • The price/operating cash flow metric for IDEXX LABORATORIES INC is higher than 92.76% of stocks in our set with a positive cash flow.
  • IDXX's price/sales ratio is 9.92; that's higher than the P/S ratio of 90.88% of US stocks.
  • If you're looking for stocks that are quantitatively similar to IDEXX LABORATORIES INC, a group of peers worth examining would be FTV, CARR, GGG, XYL, and CSGP.
  • Visit IDXX's SEC page to see the company's official filings. To visit the company's web site, go to

IDXX Valuation Summary

  • IDXX's price/sales ratio is 9.9; this is 482.35% higher than that of the median Healthcare stock.
  • Over the past 243 months, IDXX's price/sales ratio has gone up 6.2.

Below are key valuation metrics over time for IDXX.

Stock Date P/S P/B P/E EV/EBIT
IDXX 2023-11-03 9.9 27.5 43.3 33.7
IDXX 2023-11-02 9.7 26.8 42.3 33.0
IDXX 2023-11-01 9.2 25.3 39.9 31.1
IDXX 2023-10-31 9.4 30.3 41.9 32.6
IDXX 2023-10-30 9.4 30.1 41.6 32.3
IDXX 2023-10-27 9.2 29.7 41.1 31.9

IDXX Growth Metrics

    Its 5 year price growth rate is now at 65.5%.
  • Its 2 year net cashflow from operations growth rate is now at 64.77%.
  • Its year over year revenue growth rate is now at 14.56%.
IDXX's revenue has moved up $1,197,347,000 over the prior 52 months.

The table below shows IDXX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,367.324 542.984 679.089
2022-09-30 3,339.846 579.52 669.653
2022-06-30 3,308.606 577.725 663.95
2022-03-31 3,274.202 745.83 734.553
2021-12-31 3,215.36 755.546 744.845
2021-09-30 3,135.208 764.516 756.864

IDXX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IDXX has a Quality Grade of A, ranking ahead of 96.19% of graded US stocks.
  • IDXX's asset turnover comes in at 1.342 -- ranking 14th of 680 Pharmaceutical Products stocks.
  • IMGN, RMTI, and MTEX are the stocks whose asset turnover ratios are most correlated with IDXX.

The table below shows IDXX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.342 0.588 0.424
2021-03-31 1.325 0.589 0.389
2020-12-31 1.322 0.580 0.344
2020-09-30 1.341 0.576 0.319
2020-06-30 1.332 0.572 0.314
2020-03-31 1.366 0.567 0.313

IDXX Price Target

For more insight on analysts targets of IDXX, see our IDXX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $717.50 Average Broker Recommendation 1.56 (Moderate Buy)

IDEXX Laboratories Inc. (IDXX) Company Bio

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands, IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions (as of 7 February 2020). There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy (LPD). In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. (Source:Wikipedia)

IDXX Latest News Stream

Event/Time News Detail
Loading, please wait...

IDXX Latest Social Stream

Loading social stream, please wait...

View Full IDXX Social Stream

Latest IDXX News From Around the Web

Below are the latest news stories about IDEXX LABORATORIES INC that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) received a lot of attention from a substantial price increase on the NASDAQGS...

Yahoo | November 23, 2023

ALC or IDXX: Which Is the Better Value Stock Right Now?

ALC vs. IDXX: Which Stock Is the Better Value Option?

Yahoo | November 16, 2023

IDEXX Laboratories (IDXX) Declined on Weak Clinical Visits Across the Industry

Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite declined 8.01% net of fees in the third quarter, trailing the Russell Midcap Growth Index’s -5.22% return. A combination of negative stock selection and sector allocation effects resulted […]

Yahoo | November 16, 2023

IDEXX's (IDXX) Upcoming Launch to Detect Canine Leishmaniosis

IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.

Yahoo | November 13, 2023

IDEXX Laboratories (IDXX) Fell on Investors’ Concerns

Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter. Against this backdrop, the Baron Asset Fund declined 4.42% (Institutional Shares) in the […]

Yahoo | November 11, 2023

Read More 'IDXX' Stories Here

IDXX Price Returns

1-mo 22.07%
3-mo -5.61%
6-mo 2.50%
1-year 9.89%
3-year 3.15%
5-year 136.85%
YTD 18.30%
2022 -38.04%
2021 31.73%
2020 91.43%
2019 40.38%
2018 18.95%

Continue Researching IDXX

Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:

Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!